Elan completes recovery plan ahead of target
Pharmaceutical company Elan Corporation, has announced the completion of the sale of its European sales and marketing business to Medeus Pharma, a new UK pharmaceutical company backed by private equity firm Apax Partners Funds.
Elan has raised around $120m (€93.7m) from the sale, which was first announced in late December.